Ampio: Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

Ampio Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 8.63 million compared to USD 16.34 million a year ago. Basic loss per share from continuing operations was USD 10.66 compared to USD 21.68 a year ago. Diluted loss per share from continuing operations was USD 10.66 compared to USD 29.32 a year ago.